Anda belum login :: 23 Nov 2024 04:47 WIB
Home
|
Logon
Hidden
»
Administration
»
Collection Detail
Detail
Valuation - What You Need to Know
Oleh:
Frei, Patrik
;
Leleux, Benoit F.
Jenis:
Article from Journal - ilmiah internasional
Dalam koleksi:
Nature Biotechnology: The Science and Business of Biotechnology vol. 22 no. 8 (Agu. 2004)
,
page 1049-1052.
Topik:
valuation
;
valuation
Ketersediaan
Perpustakaan Pusat (Semanggi)
Nomor Panggil:
NN9.1
Non-tandon:
1 (dapat dipinjam: 0)
Tandon:
tidak ada
Lihat Detail Induk
Isi artikel
Valuing a company has always been more art that science. At the best of times, it is a trricky and difficult task, especially for early stage, biotech companies. The so called pre money valuation (which takes place before a company is financed) dictates how equity is divided among a company's investors and entrepreneurs. Those entrepreneurs follhardy enough to ignore the need for a proper valuation before they begin seeking capital not only may find themselves at a disadvantage in negotiations with investors, but also may have no way of rectifying a situation if the company valuation is suboptimal. In contrast, those who prepare a through valuation of their venture often gain a strong negotiating position, even in a buyer's market. Every startup should thus enter financing negotiations with a clear understanding of its value drivers to obtain a fair and full valuation. In this article, we provide a basic outline of how to conduct a proper valuation exercise and present two common methods used to value an early stage biotech company.
Opini Anda
Klik untuk menuliskan opini Anda tentang koleksi ini!
Kembali
Process time: 0.015625 second(s)